Literature DB >> 25795716

Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern.

Julio Finalet Ferreiro1, Julie Morscio2, Daan Dierickx3, Lukas Marcelis2, Gregor Verhoef3, Peter Vandenberghe1, Thomas Tousseyn2, Iwona Wlodarska4.   

Abstract

Entities:  

Keywords:  11q; Burkitt lymphoma; PTLD; post-transplant lymphoproliferative disease

Mesh：

Substances：

Year:  2015        PMID： 25795716      PMCID： PMC4486241          DOI： 10.3324/haematol.2015.124305

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement.

Authors:  Barbara Pienkowska-Grela; Grzegorz Rymkiewicz; Beata Grygalewicz; Renata Woroniecka; Paulina Krawczyk; Katarzyna Czyz-Domanska; Jan Walewski
Journal:  Med Oncol       Date:  2010-07-27       Impact factor: 3.064

2.  Molecular diagnosis of Burkitt's lymphoma.

Authors:  Sandeep S Dave; Kai Fu; George W Wright; Lloyd T Lam; Philip Kluin; Evert-Jan Boerma; Timothy C Greiner; Dennis D Weisenburger; Andreas Rosenwald; German Ott; Hans-Konrad Müller-Hermelink; Randy D Gascoyne; Jan Delabie; Lisa M Rimsza; Rita M Braziel; Thomas M Grogan; Elias Campo; Elaine S Jaffe; Bhavana J Dave; Warren Sanger; Martin Bast; Julie M Vose; James O Armitage; Joseph M Connors; Erlend B Smeland; Stein Kvaloy; Harald Holte; Richard I Fisher; Thomas P Miller; Emilio Montserrat; Wyndham H Wilson; Manisha Bahl; Hong Zhao; Liming Yang; John Powell; Richard Simon; Wing C Chan; Louis M Staudt
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

3.  A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.

Authors:  Itziar Salaverria; Idoia Martin-Guerrero; Rabea Wagener; Markus Kreuz; Christian W Kohler; Julia Richter; Barbara Pienkowska-Grela; Patrick Adam; Birgit Burkhardt; Alexander Claviez; Christine Damm-Welk; Hans G Drexler; Michael Hummel; Elaine S Jaffe; Ralf Küppers; Christine Lefebvre; Jasmin Lisfeld; Markus Löffler; Roderick A F Macleod; Inga Nagel; Ilske Oschlies; Maciej Rosolowski; Robert B Russell; Grzegorz Rymkiewicz; Detlev Schindler; Matthias Schlesner; René Scholtysik; Carsten Schwaenen; Rainer Spang; Monika Szczepanowski; Lorenz Trümper; Inga Vater; Swen Wessendorf; Wolfram Klapper; Reiner Siebert
Journal:  Blood       Date:  2014-01-07       Impact factor: 22.113

4.  A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.

Authors:  Michael Hummel; Stefan Bentink; Hilmar Berger; Wolfram Klapper; Swen Wessendorf; Thomas F E Barth; Heinz-Wolfram Bernd; Sergio B Cogliatti; Judith Dierlamm; Alfred C Feller; Martin-Leo Hansmann; Eugenia Haralambieva; Lana Harder; Dirk Hasenclever; Michael Kühn; Dido Lenze; Peter Lichter; Jose Ignacio Martin-Subero; Peter Möller; Hans-Konrad Müller-Hermelink; German Ott; Reza M Parwaresch; Christiane Pott; Andreas Rosenwald; Maciej Rosolowski; Carsten Schwaenen; Benjamin Stürzenhofecker; Monika Szczepanowski; Heiko Trautmann; Hans-Heinrich Wacker; Rainer Spang; Markus Loeffler; Lorenz Trümper; Harald Stein; Reiner Siebert
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

Review 5.  Deubiquitinases in cancer: new functions and therapeutic options.

Authors:  J M Fraile; V Quesada; D Rodríguez; J M P Freije; C López-Otín
Journal:  Oncogene       Date:  2011-09-26       Impact factor: 9.867

6.  Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes.

Authors:  Pier Paolo Piccaluga; Giulia De Falco; Manjunath Kustagi; Anna Gazzola; Claudio Agostinelli; Claudio Tripodo; Eleonora Leucci; Anna Onnis; Annalisa Astolfi; Maria Rosaria Sapienza; Cristiana Bellan; Stefano Lazzi; Lynnette Tumwine; Michael Mawanda; Martin Ogwang; Valeria Calbi; Serena Formica; Andrea Califano; Stefano A Pileri; Lorenzo Leoncini
Journal:  Blood       Date:  2011-01-18       Impact factor: 22.113

7.  Gene expression profiling reveals clear differences between EBV-positive and EBV-negative posttransplant lymphoproliferative disorders.

Authors:  J Morscio; D Dierickx; J F Ferreiro; A Herreman; P Van Loo; E Bittoun; G Verhoef; P Matthys; J Cools; I Wlodarska; C De Wolf-Peeters; X Sagaert; T Tousseyn
Journal:  Am J Transplant       Date:  2013-03-14       Impact factor: 8.086

8.  Clinicopathological characteristics of posttransplant lymphoproliferative disorders of T-cell origin: single-center series of nine cases and meta-analysis of 147 reported cases.

Authors:  An Herreman; Daan Dierickx; Julie Morscio; Jordi Camps; Emilie Bittoun; Gregor Verhoef; Christiane De Wolf-Peeters; Xavier Sagaert; Thomas Tousseyn
Journal:  Leuk Lymphoma       Date:  2013-03-27

9.  Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases.

Authors:  Julie Morscio; Daan Dierickx; Jan Nijs; Gregor Verhoef; Emilie Bittoun; Xanne Vanoeteren; Iwona Wlodarska; Xavier Sagaert; Thomas Tousseyn
Journal:  Am J Surg Pathol       Date:  2014-07       Impact factor: 6.394

10.  Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma.

Authors:  Julio Finalet Ferreiro; Leila Rouhigharabaei; Helena Urbankova; Jo-Anne van der Krogt; Lucienne Michaux; Shashirekha Shetty; Laszlo Krenacs; Thomas Tousseyn; Pascale De Paepe; Anne Uyttebroeck; Gregor Verhoef; Tom Taghon; Peter Vandenberghe; Jan Cools; Iwona Wlodarska
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240
View more
  21 in total

1.  The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.

Authors:  Rabea Wagener; Julian Seufert; Francesco Raimondi; Susanne Bens; Kortine Kleinheinz; Inga Nagel; Janine Altmüller; Holger Thiele; Daniel Hübschmann; Christian W Kohler; Peter Nürnberg; Rex Au-Yeung; Birgit Burkhardt; Heike Horn; Lorenzo Leoncini; Elaine S Jaffe; German Ott; Grzegorz Rymkiewicz; Matthias Schlesner; Robert B Russell; Wolfram Klapper; Reiner Siebert
Journal:  Blood       Date:  2018-12-19       Impact factor: 22.113

Review 2.  Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.

Authors:  Arantza Onaindia; L Jeffrey Medeiros; Keyur P Patel
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

Review 3.  The clinicopathologic spectrum of mature aggressive B cell lymphomas.

Authors:  Lisa Rimsza; Stefania Pittaluga; Stephan Dirnhofer; Christiane Copie-Bergman; Laurence de Leval; Fabio Facchetti; Stefano Pileri; Andreas Rosenwald; Andrew Wotherspoon; Falko Fend
Journal:  Virchows Arch       Date:  2017-08-26       Impact factor: 4.064

Review 4.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

5.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Hematolymphoid Tumours.

Authors:  Noah A Brown; Kojo S J Elenitoba-Johnson
Journal:  Head Neck Pathol       Date:  2017-02-28

6.  A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration.

Authors:  Grzegorz Rymkiewicz; Beata Grygalewicz; Magdalena Chechlinska; Katarzyna Blachnio; Zbigniew Bystydzienski; Joanna Romejko-Jarosinska; Renata Woroniecka; Michalina Zajdel; Katarzyna Domanska-Czyz; David Martin-Garcia; Ferran Nadeu; Pawel Swoboda; Jolanta Rygier; Barbara Pienkowska-Grela; Jan Konrad Siwicki; Monika Prochorec-Sobieszek; Itziar Salaverria; Reiner Siebert; Jan Walewski
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

Review 7.  New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.

Authors:  Leticia Quintanilla-Martinez; Steven H Swerdlow; Thomas Tousseyn; Carlos Barrionuevo; Shigeo Nakamura; Elaine S Jaffe
Journal:  Virchows Arch       Date:  2022-10-11       Impact factor: 4.535

Review 8.  Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.

Authors:  Ryan C Lynch; Dita Gratzinger; Ranjana H Advani
Journal:  Curr Treat Options Oncol       Date:  2017-07

9.  Burkitt-like lymphoma in a pediatric patient with familial adenomatous polyposis.

Authors:  Katie M Strobel; Jacquelyn N Crane; Kathryn L Bradford; Yalda Naeini; William A May; Vivian Y Chang
Journal:  Cancer Genet       Date:  2019-09-04

Review 10.  Novel Biological Insights and New Developments in Management of Burkitt Lymphoma and High-Grade B-Cell Lymphoma.

Authors:  Coen J Lap; Samah Nassereddine; Kieron Dunleavy
Journal:  Curr Treat Options Oncol       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.